Using chromosome banding and fluorescence in situ hybridization (FISH) (9) 
INTRODUCTION
During the last decade in Western countries, the apparent incidence of prostate cancer has shown a tremendous rise mainly because of improved diagnostic modalities, such as the tumor marker prostate-specific antigen [1] . In comparison, the age adjusted cancer-specific mortality has not increased significantly, suggesting that prostate cancers may be diagnosed in the latent stage and that the risk of over treatment should be considered [2] . Nevertheless, prostate carcinoma is one of the leading causes of cancer mortality in the male. Therefore, because of the uncertain behavior and heterogeneous nature of the disease, the establishment of methods to distinguish clinically insignificant from potentially lethal cancers has become the future challenge for prostate cancer research. The development of human models for prostate carcinogenesis may allow for the identification of specific tumorigenic features. Even with continuous progress [3] , the possibilities to study primary cells from the human prostate epithelium are limited by their short lifespan in culture. In search for an in vitro model of human prostate carcinogenesis, we used HPV type 18 DNA to immortalize epithelial cell cultures. Two cell lines were established: PZ-HPV-7, an epithelial precursor cell derived from normal prostatic peripheral zone tissue, and CA-HPV-10, an epithelial precursor cell derived from a high-grade adenocarcinoma of the prostate [4] .
Characteristic cytogenetic aberrations may shed some light on tumor specific mechanisms of oncogenesis. During the last decade, several chromosomal abnormalities have been associated with prostate adenocarcinoma. The findings of specific karyotypic features of adenocarcinoma specimens have been significant. Chrosomomal gains and losses as well as structural anomalies reported in prostate cancer include almost all human chromosomes, i.e., 1, 2, 3, 5, 6, 7, 8, 9, 10, 13, 14, 15, 16, 17, 18, 22 , X, and Y [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Of these chromosomal anomalies some seem to predominate. Gains of chromosomes X and 7, and 8q may be involved in prostate cancer progression [11] [12] [13] [14] [15] [16] [17] . Among the most commonly deleted regions implicated in prostate cancer we find 8p [6] [7] [8] [9] [10] [13] [14] [15] [16] [17] , first suggested in 1988 by König et al. [19] , 10q [5-8, 13, 17] , 16q [5, 6, 13, 17] , and also anomalies of the Y chromosome [7, 8, 10, [14] [15] [16] . Furthermore, linkage analysis of 91 high-risk prostate cancer families recently provided strong evidence of a major prostate cancer supsceptibility locus on chromosome 1 [18] . Interestingly, one of the newly established HPV transformed cell lines, CA-HPV-10, was derived from a human prostate cancer cell strain with several karyotypic abnormalities, including an extra Y chromosome and double minutes (dmin) [7] .
In this study, we report on the sequential analysis of both prostate cell lines and a detailed characterization of CA-HPV-10 marker chromosomes using whole chromosome paints and site specific probes. The HPV integration sites were also investigated using fluorescence in situ hybridization (FISH) methodology.
MATERIALS AND METHODS

Cell Lines
As reported previously [4] , plasmids containing the full genome of HPV type 18 incubated with lipofectin (BRL Life Technologies, Gaithersburg, MD) were used for immortalization of two primary epithelial human prostate cell strains, LJpz and HSca. The two established cell lines-PZ-HPV-7, precursor LJpz derived from normal prostatic peripheral zone epithelium, and CA-HPV-10, precursor HSca derived from a high-grade (Gleason grade 4 ϩ 4) prostatic adenocarcinoma specimen-were analyzed at different passages ranging from early (15 and 14) to late (99 and 94) numbers. Keratinocyte serum free media KSFM (GIBCO, Grand Island, NY), added with bovine pituitary extract (50 ug/ml), epidermal growth factor (5 ng/ ml) and antibiotics was required for optimal growth.
Cytogenetics
Monolayers of in log phase growing cultures were incubated with colcemid (0.015 g/ml) for 30 min to one hour. Longer incubation was required when limited numbers of rounded or mitotic cells were observed. Subsequently, metaphase cells were harvested by trypsinization, swollen in KCl-EGTA (0.075M), fixed in methanol:acetic acid (3:1), and spread on slides [19] . Chromosomes were identified by the R-banding and Q-banding technique using acridineorange and atebrine, respectively. At least 20 metaphases from each cell line were karyotyped.
Fluorescence in Situ Hybridization (FISH)
The DNA probes were labeled with Biotin-16-dUTP by standard nick translation, precipitated, and resuspended in hybridization mixture (50% formamide, 10% dextran sulfate in 2 ϫ SSCP) with 50 g salmon sperm DNA and 50 g yeast t-RNA when competitive hybridization was necessary. The probe concentration was as follows: 0.5 ng/ l for centromeric probes, 7.5 ng/ l for the HPV probe, and 10 ng/ l for chromosome-specific libraries. After probe denaturation (4 min at 72 Њ C), the repeat sequences were allowed to preanneal with 10 g Cot-1 DNA for 1 hour at 37 Њ C. Metaphase spreads on glass were pretreated with RNAse and 0.2% pepsin (0.01 N HCl), postfixed, and denatured at 72 Њ C for 2.5 min in 70% formamide. Probes were hybridized overnight at 37 Њ C in a humidified box. After washing, the hybridization sites were visualized by immunochemistry using two layers of FITC in three steps with avidin-FITC, biotinylated goat-anti-avidin, and avidin-FITC. Results were observed in fluorescence using DAPI banding counterstaining and sometimes cohybridization with a known probe relevant for chromosome identification.
Probes
Various probes were used, single or in combination, in single or double color experiments.
HPV type 18. The full plasmid of HPV type 18 DNA cloned into pB322 (kindly received from Dr. E-M. de Villiers, Heidelberg, Germany) was used as a probe.
Whole chromosome paint. Chromosome specific libraries pBS 1 to 22, X, and Y, prepared and made available to us by J. Gray (University of California, San Francisco, USA). Separate experiments were performed using a commercially available chromosome 11 probe (Cambio LTD) as well as chromosomes 4 and 9 probes prepared by degenerate oligonucleotide-primed-polymerase chain reaction (DOP-PCR)-amplification [20] .
Centromere probes. Probe PUC1.77 [21] for chromosome 1, pYAM11-39 [22] for 4, D8Z2 [23] for 8, pHUR98 [24] for 9, pLC11A [25] for 11, pHUR195 [24] for 16, L1.84 [26] for 18, and p3.4 [27] for 20 were used.
Gene loci specific probes. Site or gene loci-specific probe p1.79 (received from H. van Dekken, Rotterdam, The Netherlands) was used for identification of 1p36; oct 7a (received from R. de Zwart, Rotterdam, The Netherlands) was used for 1p32/2q23; ERCC3 [28] was used for 2q, 10.62/10.63; p16 tumor suppressor gene [29] was used for 9p21; and Cos-ABL-18 [30] was used for 9q34.
RESULTS
Cytogenetic Analysis
The PZ-HPV-7 cell line, precursor originating from a normal prostatic epithelial cell strain, was studied at passages 15, 38, and 99. PZ-HPV-7 progressed from an initial diploid chromosome number at passage 15 and 38 to a modal number of 106 chromosome, range 103 to 108. Analysis showed 3 to 5 copies of all chromosomes except X and Y (2 copies each) and chromosomes 5 and 20 (7 to 8 copies each). There were only a few structural changes: 3p Ϫ (M1, 2 copies), 3q Ϫ (M2, 1 copy), and a third marker possibly a der(16p;12q)(M3). In Figure 1A the full karyotype is shown representing the late passage findings as described above.
The CA-HPV-10 parental cell strain HSca originated from a core of pure Gleason grade 4 ϩ 4 prostatic adenocarcinoma obtained from a radical prostatectomy specimen. The previously reported karyotype of HSca [7] showed several abnormalities including an extra Y chromosome and dmin. At passages 14 and 38, the karyotypes of cell line CA-HPV-10 varied from hypodiploid to hypotetraploid with a slowly rising mode in the hypertriploid range. The karyotype was unstable with mainly telomeric associations, di-and tricentric chromosomes, isochromosomes, and a decreasing number of cells exhibiting dmin. At passage 89 the karyotype was mainly hypertriploid (modal number 72, range 69 to 75) with a few cells hyperhexaploid and hyperdodecaploid. Consistent markers included two copies each of del(1)(q12q31) (M1) and der(9)t(1;9)(?;p22) (M2) with probably a large hsr, one der(11)t(4;11)(?;q21) (M3) and one structurally abnormal der(16)(M4). Chromosomes 20 and 5 were overrepresented with an average of 4 and 5 copies, respectively. Loss of Y (0 to 1 copies), as well as the relative loss of chromosomes 6, 13 (2 to 3 copies), and 22 (2 copies) was remarkable. ure 1B shows the full karyotype of the CA-HPV-10 cell line in late passage as described above.
For identification of CA-HPV-10 markers, detailed FISH analyses were performed. In initial experiments DOP-PCRamplified flow-sorted chromosomes 4 and 9, and a commercially available chromosome 11 probe was used on metaphase spreads of cell line CA-HPV-10 (passage 89) to identify the 11q ϩ and 9p ϩ markers. These single chromosomal paints of chromosomes 4, 9, and 11, as well as cohybridization experiments of 4 and 11 revealed a der(11)t(4;11), whereas the hsr on 9p was investigated. Subsequently, for each chromosome, whole libraries were used as paints, sometimes in combination with specific centromeric probes. Eight to 31 metaphases were analyzed. Each paint showed numerical changes consistent with the cytogenetic findings (Table 1) as well as a number of marker chromosomes ( Table 2 ). The 9p ϩ hsr is painted with chromosome 1 specific DNA, which is shown in Figure 2 . In double staining experiments using loci-specific probes for 1p36, 1p32/ 2q23, 2q, and 9p21, the hsr was studied in detail. However, none of these probes were located on the hsr. The studied probes exhibited an otherwise expected staining pattern on the respective chromosomes 1 and 2, whereas the 9p21 probe for the p16 tumor suppressor gene revealed no deletion.
FISH Analysis of HPV 18 Incorporation Sites
Preparation of HPV 18 DNA specific probes was established using the original purified plasmid. Metaphase chromosomal spreads of Hela cells, containing several genomic copies of integrated HPV 18 DNA, were used as positive controls. At least 20 metaphases of each cell line were analyzed. Using the full HPV 18 plasmid as a probe, we obtained a strong hybridization signal in the HeLa cell line and a weak signal in our cell lines. The weaker signal was probably because of a low number of copies of the HPV 18 genome in the PZ-HPV-7 and CA-HPV-10 cell lines. Both cell lines showed single HPV type 18 genomic integration sites. For the PZ-HPV-7 cell line, the integration site was identified on 1p, whereas for the CA-HPV-10 cell line, it was identified on the 9p ϩ marker. The latter is Figure 3 in a double staining experiment with the centromere 8 probe.
DISCUSSION
As a model for the study of prostate carcinogenesis, two epithelial cell lines, PZ-HPV-7 and CA-HPV-10, have been established using HPV type 18 DNA. Immortalization with the HPV type 18 genome was attempted because HPV DNA sequences have been detected in human prostatic tissues of different histologies [31] [32] [33] [34] [35] [36] , and the detected HPV DNAs were shown to be transcriptionally active [37] , although the role of HPV in the prostate remains unclear [38] . Another reason to perform HPV transformation studies was to prolong the limited in vitro lifespan of human epithelial prostate cells per se, which had been accomplished previously using SV40 DNA [39] [40] [41] . The resulting cytogenetic changes were evaluated in the described analysis. The PZ-HPV-7 cell line, originating from a normal epithelial human prostate cell strain, was diploid and relatively unchanged at early (15 and 36) passage. PZ-HPV-7 progressed in culture to a modal number of 106 chromosomes with mostly numeric changes and only a few structural markers. In contrast, CA-HPV-10 showed a hypertriploid mode in both analyses of early and late passages, with a number of characteristic markers, which were not fully present in the earlier passages. Loss of chromosome 22 was of interest, because it was not observed in HPV immortalized keratinocyte cell lines [42] nor in HPV immortalized cell lines from other organ systems [39] [40] [41] [42] . Furthermore, the relative gain of both chromosomes 5 and 20 in the two cell lines, PZ-HPV-7 and CA-HPV-10, was remarkable. This combination has not specifically been described before as an HPV transformation related phenomenon, although a gain of chromosome 20 has been reported [43] [44] [45] .
After HPV transfection triploidization is rather commonly described as well as structural genomic rearrangements [45, 46] . Also, single site HPV DNA integration was observed in cervical carcinoma cell lines [47] . HPV sequences of cervical carcinoma cell lines integrated on normal and abnormal chromosomes. The staining pattern of HPV 16 integration sites showed evidence of replication together with the heterochromatic regions of chromosomes 1, 9, and 16 [48] . Reznikoff et al. [44] showed how the initial genetic alterations may direct late genetic changes and how different combinations of genetic alterations work together to block cellular senescence, initiate tumorigenesis, and lead to tumor progression in transitional cell carcinoma. After transfection of HPV type 16 E6, which represents one of the early gene regions involved in transformation, a specific association of 3p loss with chromosome 9 instability was found. These karyotypic changes would seem to fit the general cytogenetic features of the PZ-HPV-7 and CA-HPV-10 cell lines.
Loss of the Y chromosome is of interest in view of recent studies. Gains as well as deletions of the Y chromosome were found in prostatic carcinomas using in situ hybridization [10, [14] [15] [16] . Recently, loss of the Y-chromosome was found in metastatic prostate carcinoma specimen, whereas the primary carcinoma and adjacent prostatic intraepithelial neoplasia lesions did not show this deletion [15] . However, it is unclear whether this loss of the Y-chromosome is a relatively nonspecific or possibly significant cytogenetic correlate of progression in prostate cancer. It has been found in other urinary tract tumors [49, 50] . Our findings could be significant although cytogenetic phenomena associated with the HPV immortalization should be considered. Relative marked loss of the Y chromosome was found in the cell line CA-HPV-10, which was derived from a high-grade adenocarcinoma precursor cell strain HSca, that had an extra Y chromosome before transfection [7] . The PZ-HPV-7 cell line did not show such a prominent loss of the chromosome.
In addition to an abnormal karyotype of 47,XY, ϩ Y, the precursor cell strain of CA-HPV-10 contained dmin chromosomes. The presence of both dmin and hsr is suggestive of gene amplification events possibly representing oncogene amplification [51] , as has been reported in other solid tumors [52, 53] . The cytogenetic evaluation with banding techniques of cell line CA-HPV-10 showed an hsr on chromosome 9p. Instead of a possible complex translocation, additional painting experiments revealed the configuration of a translocation, der(11)t(4;11)(?;q21r). The hsr on 9p was studied using whole chromosome paints, which showed its chromosome 1 origin. The determination of HPV integration sites on 1p in the PZ-HPV-7 cell line and 9p ϩ in chromatin of 1 on the add(9)(p22) in the CA-HPV-10 cell line does raise the question of whether there is a preferential integration site following HPV transfection in prostate epithelial cells. Using several loci specific probes, the 9p ϩ marker was targeted; however, because none were found to be located on the hsr, the conclusions from these experiments were limited. A probe for the p16 tumor suppressor gene located on 9p21 [29] showed no deletion. The question of whether the hsr and dmin were retained in CA-HPV-10 or if they resulted from the HPV immortalization remains open. The formation of hsr as a reflection of DNA amplification has been described after HPV immortalization of keratinocytes [48] . Unfortunately, the original metaphase spreads of the CA-HPV-10 precursor HSca were not available for additional chromosomal painting, but it would seem appropriate to assume that the dmin and hsr of the CA-HPV-10 cell line have been retained from the precursor cell. Efforts to isolate these particular hsr and dmin using flow sorting techniques [20] have been unsuccessful because of the high viscosity of chromosome suspensions from these cells. Nevertheless, further studies for isolation of these aberrant chromosomal parts are warranted, because building a physical map of the involved regions could provide new insights of mechanisms involved in human prostate carcinogenesis.
The cytogenetic evaluation of PZ-HPV-7 and CA-HPV-10 revealed several karyotypic abnormalities that can be of interest in the pursuit of a multistep in vitro model of human prostate carcinogenesis. The cytogenetic modifications that were identified represent a range of HPV transfection related phenomena within the residual pattern of the original karyotype.
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